ARTICANZ - Beta (ver 0.91)
Annotated Registry of Trials in Cancer, Australia and New Zealand Ed.
- Results - catype/medical-oncology/non-melanoma-skin/advanced-metastatic
Home
By cancer type
By drug class
By site
Data
FAQ
About
⚠
ARTICANZ provides informational content about cancer drug trials in Australia/NZ that is updated weekly but may not be completely accurate, and should not replace medical advice from qualified healthcare professionals. The platform is intended to be useful, providing information "as is" without warranties. Non-medical users must always consult healthcare providers for all clinical decisions.
Search results
Melanoma and skin / Non-melanoma skin - Advanced/metastatic
6
trial(s) found.
NCT05086692
Advanced
Phase 1 / Phase 2
Recruiting
A Phase 1/2 Open Label, Dose Escalation and Expansion Study of MDNA11, IL-2 Superkine, Administered Alone or in Combination With Immune Checkpoint Inhibitor in Patients With Advanced Solid Tumors (
ABILITY-1
)
IL-2 superkine
Acral lentiginous melanoma
Bladder cancer
Cancer
Cervical cancer
Clear cell renal cell carcinoma
Colorectal cancer
Cutaneous basal cell carcinoma
Cutaneous melanoma
Cutaneous squamous cell carcinoma
Endometrial cancer
Endometrial carcinoma
Epithelial Ovarian Cancer
Fallopian tube cancer
Gastric cancer
Gastroesophageal junction adenocarcinoma
Head and neck squamous cell carcinoma
Melanoma
Merkel cell carcinoma
Mucosal melanoma
Non-melanoma skin cancer
Non-squamous non-small-cell lung cancer
Oesophageal cancer
Ovarian cancer
Pancreatic adenocarcinoma
Pleural mesothelioma
Primary peritoneal serous carcinoma
Skin cancer
Solid tumour
Squamous non-small-cell lung cancer
Triple-negative breast cancer
dMMR solid cancer
NSW
2031 - Randwick - Scientia Clinical Research Ltd
2109 - North Ryde - Macquarie University Hospital
QLD
4120 - Greenslopes - Greenslopes Private Hospital
4556 - Buderim - Sunshine Coast Haematology and Oncology Clinic
NCT04429542
Advanced
Phase 1
Recruiting
First-in-Human, Phase 1/1b, Open-label, Multicenter Study of Bifunctional EGFR/TGFβ Fusion Protein BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-Driven Advanced Solid Tumors (
BCA101X1101
)
bifunctional EGFR/TGF-beta fusion protein
Anal squamous cell carcinoma
Carcinoma
Colorectal cancer
Cutaneous squamous cell carcinoma
Epithelial Ovarian Cancer
Head and neck cancer
Head and neck squamous cell carcinoma
Pancreatic cancer
Squamous cell carcinoma
NSW
2050 - Camperdown - Chris O'Brien Lifehouse
2298 - Waratah - Calvary Mater Newcastle Medical Oncology
VIC
3000 - Melbourne - Peter MacCallum Cancer Centre
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre
ACTRN12626000435381
Advanced
Not Applicable
Recruiting
A Clinical Trial to Determine Safety and Tolerability of Targeted Osmotic Lysis in the Treatment of Well-Differentiated Cutaneous Squamous Cell Carcinoma. (
TOL-in-CSCC
)
Cutaneous squamous cell carcinoma
NSW
2305 - New Lambton Heights - Hunter New England Cancer Centre - John Hunter Hospital
ACTRN12625000197437
Advanced
Phase 2
Not yet recruiting
A single arm, phase II trial of Cemiplimab in Head and Neck Cutaneous Squamous Cell Carcinoma with Large Nerve Perineural Spread (
NIL-Known
)
anti-PD-1 monoclonal antibody
Cutaneous squamous cell carcinoma
Skin cancer
QLD
4006 - Herston - The Royal Brisbane and Women's Hospital Cancer Centre
4102 - Woolloongabba - Princess Alexandra Hospital
ACTRN12619001298101
Advanced
Phase 2
Not yet recruiting
A Phase IIa Study to assess the Efficacy and Safety of ASN-002 alone and in combination with chemotherapy in adult participants with Low-Risk Basal Cell Carcinomas (
ASN-002-IL
)
SYK/JAK inhibitor
Cutaneous basal cell carcinoma
QLD
4006 - Herston - The Royal Brisbane and Women's Hospital Cancer Centre
NCT05642949
Advanced
Phase 1 / Phase 2
Unknown
Phase 1/2, Multi-center, Open-label, Dose Escalation and Cohort Expansion Study to Evaluate the Safety/Tolerability, Pharmacokinetics and Efficacy of MHB036C in Participants With Advanced or Metastatic Solid Tumors (
MHB036C-CP001EN
)
anti-Trop2 antibody-drug conjugate
Breast cancer
Endometrial cancer
Gastric cancer
Head and neck squamous cell carcinoma
Non-small cell lung cancer
Oesophageal squamous cell carcinoma
Ovarian cancer
Pancreatic adenocarcinoma
Prostate cancer
Small-cell lung cancer
Solid tumour
Sweat gland carcinoma
Urothelial carcinoma
VIC
3144 - Malvern - GenesisCare Cabrini, Cabrini Hospital
QLD
4217 - Benowa - Pindara Private Hospital
SA
5042 - Bedford Park - Southern Oncology Clinical Research Unit
Additional search terms:
API and Webpage URLs:
Copy /Bookmark
Filters
Recruitment Status
Recruiting (3)
Not yet recruiting (2)
Unknown (1)
Recruitment Country and State
QLD (4)
NSW (3)
VIC (2)
SA (1)
Phase
Phase 1 (1)
Phase 1 / Phase 2 (2)
Phase 2 (2)
Trial Type
Advanced (6)
Cancer Therapy Class
PD-1
50%
PD-1/PD-L1
50%
IL-2
17%
JAK
17%
SYK
17%
Trop2
17%
Facility
4006 - Herston - The Royal Brisbane and Women's Hospital Cancer Centre (2)
2031 - Randwick - Scientia Clinical Research Ltd (1)
2109 - North Ryde - Macquarie University Hospital (1)
4120 - Greenslopes - Greenslopes Private Hospital (1)
4556 - Buderim - Sunshine Coast Haematology and Oncology Clinic (1)
2050 - Camperdown - Chris O'Brien Lifehouse (1)
2298 - Waratah - Calvary Mater Newcastle Medical Oncology (1)
3000 - Melbourne - Peter MacCallum Cancer Centre (1)
3084 - Heidelberg - Austin Hospital Olivia Newton-John Cancer Centre (1)
2305 - New Lambton Heights - Hunter New England Cancer Centre - John Hunter Hospital (1)
4102 - Woolloongabba - Princess Alexandra Hospital (1)
3144 - Malvern - GenesisCare Cabrini, Cabrini Hospital (1)
4217 - Benowa - Pindara Private Hospital (1)
5042 - Bedford Park - Southern Oncology Clinical Research Unit (1)
Cancer Type
Cancer
Non-melanoma skin cancer
Skin cancer
Solid tumour
Cutaneous squamous cell carcinoma
Gastrointestinal cancer
Gynaecological cancer
Head and neck cancer
Head and neck squamous cell carcinoma
Ovarian cancer
Pancreatic cancer
Pancreatobiliary cancer
Upper gastrointestinal cancer
Breast cancer
Colorectal cancer
Cutaneous basal cell carcinoma
Endometrial cancer
Epithelial Ovarian Cancer
Exocrine pancreatic cancer
Gastric cancer
Gastroesophageal cancer
HPV-related cancer
HPV16-positive cancer
Lower gastrointestinal cancer
Lung cancer
Non-small cell lung cancer
Oesophageal cancer
Pancreatic adenocarcinoma
Respiratory tract cancer
Thoracic cancer
Urogenital cancer
Viral-related cancer
Carcinoma
Acral lentiginous melanoma
Biomarker-defined solid tumour
Bladder cancer
Breast adenocarcinoma
Cervical cancer
Clear cell renal cell carcinoma
Cutaneous melanoma
Endometrial carcinoma
Fallopian tube cancer
Gastric carcinoma
Gastroesophageal junction adenocarcinoma
High-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
Kidney cancer
MSI-H/dMMR solid tumour
Melanoma
Merkel cell carcinoma
Mesothelioma
Mucosal melanoma
Non-squamous non-small-cell lung cancer
Peritoneal cancer
Pleural mesothelioma
Primary peritoneal serous carcinoma
Squamous non-small-cell lung cancer
Triple-negative breast cancer
dMMR solid cancer
Anal cancer
Anal squamous cell carcinoma
Squamous cell carcinoma
Male genital cancers
Neuroendocrine carcinoma
Oesophageal squamous cell carcinoma
Prostate cancer
Small-cell lung cancer
Small-cell neuroendocrine carcinoma
Sweat gland carcinoma
Urothelial carcinoma
URLs for this search
API URL:
Copy
Bookmarkable URL:
Copy